IRIS UniCatt

Tumbarello, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.159
EU - Europa 10.659
AS - Asia 9.193
SA - Sud America 1.622
Continente sconosciuto - Info sul continente non disponibili 344
AF - Africa 246
OC - Oceania 22
AN - Antartide 1
Totale 35.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.845
DE - Germania 4.215
SG - Singapore 3.878
CN - Cina 2.927
BR - Brasile 1.299
SE - Svezia 1.265
IT - Italia 1.149
UA - Ucraina 846
FR - Francia 839
VN - Vietnam 641
PL - Polonia 558
GB - Regno Unito 468
IE - Irlanda 376
IN - India 305
FI - Finlandia 276
TR - Turchia 270
ID - Indonesia 261
RU - Federazione Russa 215
BD - Bangladesh 183
HK - Hong Kong 174
JP - Giappone 148
CA - Canada 128
AR - Argentina 126
MX - Messico 109
NL - Olanda 82
IQ - Iraq 78
ZA - Sudafrica 71
BE - Belgio 57
AT - Austria 56
ES - Italia 56
EC - Ecuador 50
MA - Marocco 43
CO - Colombia 40
SA - Arabia Saudita 33
PK - Pakistan 32
VE - Venezuela 31
IR - Iran 26
UZ - Uzbekistan 25
RO - Romania 24
IL - Israele 23
CH - Svizzera 22
PH - Filippine 22
KR - Corea 21
TN - Tunisia 21
EG - Egitto 19
JO - Giordania 19
LT - Lituania 19
AE - Emirati Arabi Uniti 18
CL - Cile 18
KE - Kenya 17
AU - Australia 16
JM - Giamaica 16
PE - Perù 16
BG - Bulgaria 15
CZ - Repubblica Ceca 15
UY - Uruguay 15
BO - Bolivia 14
GR - Grecia 14
HU - Ungheria 13
KZ - Kazakistan 13
CI - Costa d'Avorio 12
CR - Costa Rica 12
EU - Europa 12
DZ - Algeria 11
ET - Etiopia 11
HN - Honduras 11
NP - Nepal 11
PT - Portogallo 10
PY - Paraguay 10
AL - Albania 9
LY - Libia 9
AZ - Azerbaigian 8
LV - Lettonia 8
OM - Oman 8
BZ - Belize 7
HR - Croazia 7
MY - Malesia 7
TH - Thailandia 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
NG - Nigeria 6
RS - Serbia 6
BH - Bahrain 5
KG - Kirghizistan 5
LK - Sri Lanka 5
MD - Moldavia 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
VA - Santa Sede (Città del Vaticano) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LB - Libano 4
MU - Mauritius 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AM - Armenia 3
AO - Angola 3
Totale 34.842
Salva come PNG Salva come JPEG
Città #
Singapore 2.020
Chandler 1.522
Ashburn 1.306
San Jose 1.056
Hangzhou 626
Jacksonville 575
Beijing 436
Warsaw 436
San Mateo 399
Nanjing 376
Dublin 371
Ann Arbor 361
Dearborn 302
New York 281
Woodbridge 270
Wilmington 267
Nürnberg 266
Los Angeles 249
Jakarta 236
Ho Chi Minh City 207
Izmir 207
Lauterbourg 202
Houston 198
Boston 181
Hanoi 165
Munich 163
Hefei 162
Hong Kong 159
Milan 155
The Dalles 152
Fairfield 146
Lawrence 140
Seattle 140
Moscow 138
Frankfurt am Main 134
Tokyo 132
Chicago 130
São Paulo 130
Nanchang 128
Cattolica 125
Marseille 121
Rome 118
Redwood City 106
Kraków 104
Buffalo 95
Dallas 84
Princeton 81
Santa Clara 78
Shenyang 73
Guangzhou 71
Kunming 70
Tianjin 67
Bremen 66
Boardman 63
Mountain View 62
Hebei 61
Helsinki 59
Lancaster 58
Brussels 56
Norwalk 55
St Louis 51
Zhengzhou 51
Brooklyn 48
London 48
University Park 47
Orem 44
Cambridge 43
Atlanta 42
Changsha 41
Jiaxing 41
Paris 41
Redmond 40
Phoenix 39
Shanghai 38
Toronto 38
Falls Church 37
Kent 37
Rio de Janeiro 37
Council Bluffs 36
Baghdad 35
Da Nang 35
Montreal 34
Nuremberg 34
San Francisco 34
Vienna 34
Johannesburg 33
Jinan 32
Fremont 31
Pune 31
Belo Horizonte 28
Leawood 28
Chennai 27
Dhaka 26
Haiphong 26
Amsterdam 25
Mexico City 24
Augusta 23
Brasília 23
Denver 23
Hyderabad 22
Totale 17.604
Salva come PNG Salva come JPEG
Nome #
Factors associated with mortality in bacteremic patients with haematologic malignancies 470
A prospective survey of febrile events in hematological malignancies 404
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 404
Factors associated with mortality in bacteremic patients with hematologic malignancies. 379
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 360
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 358
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 357
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 315
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 311
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 311
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 309
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 299
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 297
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 296
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 286
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 281
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 264
A prospective survey of febrile events in hematological malignancies 255
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 255
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 250
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 249
Whole-genome sequencing reveals host factors underlying critical COVID-19 245
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 240
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 240
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 240
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 235
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 231
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 225
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 219
Factors associated with mortality in bacteremic patients with hematologic malignancies. 219
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 212
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 211
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 210
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 204
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 200
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 198
Meropenem/ vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 198
The role of carbapenem-resistant pathogens in cSSTI and how to manage them 198
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 197
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 197
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 196
Safety and effectiveness of transvenous lead extraction in octogenarians 196
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 192
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 192
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 191
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 188
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 187
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 184
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 184
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 183
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 182
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 182
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 181
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 179
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 178
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 178
Neurological involvement during legionellosis, look beyond the lung 177
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 174
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 174
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 172
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 171
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 171
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 170
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 170
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 167
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 166
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 166
An explainable model of host genetic interactions linked to COVID-19 severity 165
Mortality in patients with early- or late-onset candidaemia 164
Attitudes and practices of dentists treating HIV patients in HAART era. 163
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 161
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 161
Oral lesions in HIV and HCV co-infected individuals in HAART era 160
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 160
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 159
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 157
A prospective survey of febrile events in hematological malignancies 157
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 156
Dental hygienists behaviour towards HIV-positive patients in highly active antiretroviral therapy era: a pilot survey 156
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 156
Dental care and HIV-infected individuals: are they equally treated? 156
Neurological involvement during Legionellosis, look beyond the lung 156
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 156
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 155
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 155
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 155
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy 154
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 153
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 153
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 153
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 152
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 151
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 150
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 150
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study 149
Oral lesions in HIV and HCV co-infected individuals in HAART era 148
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART. 148
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 148
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 148
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 147
Totale 20.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.938 0 204 73 119 120 111 37 364 101 137 270 402
2022/20234.076 479 557 314 580 287 518 177 317 494 133 153 67
2023/20241.776 110 581 46 83 56 226 106 73 27 60 176 232
2024/20253.812 118 131 288 139 392 118 123 206 611 328 719 639
2025/202610.292 1.575 281 519 1.077 1.911 535 1.801 514 665 778 365 271
2026/20271.318 406 912 0 0 0 0 0 0 0 0 0 0
Totale 35.246